Table 4.
Clinicopathological characteristics of patients with uterine cancer according to P1 tumor engraftment status.
| Successful Engraftment | ||||||
|---|---|---|---|---|---|---|
| Variables | Case | Successful Engraftment | Failed Engraftment | p Value | Tumor Growth Rate a | p Value e |
| All, n | 32 | 18 | 14 | |||
| Age (year) a | 56.44 ± 10.01 | 58.44 ± 8.361 | 53.86 ± 11.60 | 0.2032 c | ||
| Pre CA-125 level (U/mL) a | 477.7 ± 1574 | 307.7 ± 914.9 | 740.3 ± 2286 | 0.4880 c | ||
| Histology, n (%) | 0.1595 d | |||||
| Endometrioid | 22 (68.75) | 10 (55.56) | 12 (85.71) | 288.4 ± 342.9 | reference | |
| Serous | 5 (15.63) | 4 (22.22) | 1 (7.14) | 429.5 ± 532.7 | 0.7091 | |
| Clear | 1 (3.13) | 1 (5.56) | 0 (0.0) | 338.2 | N/A | |
| Carcinosarcoma | 3 (9.38) | 3 (16.67) | 0 (0.0) | 1127 ± 1088 | 0.476 | |
| Other b | 1 (3.13) | 0 (0.0) | 1 (7.14) | N/A | N/A | |
| Stage, n (%) | 1.0000 d | |||||
| I/II | 23 (71.88) | 13 (72.22) | 10 (71.43) | 363.9 ± 559.0 | reference | |
| III/IV/Recurrent | 9 (28.13) | 5 (27.78) | 4 (28.57) | 617.8 ± 275.4 | 0.2565 | |
| Grade, n (%) | 0.0025 d | |||||
| 1 | 4 (12.50) | 0 (0) | 4 (12.50) | N/A | ||
| 2 | 13 (40.63) | 5 (15.63) | 8 (25.00) | 330.1 ± 477.3 | reference | |
| 3 | 11 (34.38) | 10 (31.25) | 1 (3.16) | 358.4 ± 293.8 | 0.919 | |
| Unknown | 4 (12.50) | 3 (9.38) | 1 (3.16) | 966.4 ± 1316 | N/A | |
a Values are mean ± standard derivation. b Other includes endometrial stromal sarcoma. c Unpaired t-test for success and failure. d Fisher’s exact test or chi-square test. e Unpaired t-test with Welch’s correction. Unknown data was excluded in calculation of p value. N/A, not applicable.